Journal of Medical Oncology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +441518081136

Mini Review - Journal of Medical Oncology and Therapeutics (2023) Volume 8, Issue 6

Ovarian cancer risk factors: what every woman should know

William Hen *

Department of Health Sciences, Tianjin Medical University ,China

*Corresponding Author:
William Hen
Department of Health Sciences, Tianjin Medical University, China
E-mail: willhen@cicams.ac.cn

Received: 27-Oct-2023, Manuscript No. AARA-23-121689; Editor assigned: 28-Oct-2023, PreQC No. AARA-23-121689 (PQ); Reviewed:09- Nov -2023, QC No. AARA-23-121689; Revised:16- Nov -2023, Manuscript No. AARA-23-121689 (R); Published:: 23- Nov -2023, DOI:10.35841/aara-8.6.180

Citation: Hen W. Ovarian cancer awareness month: spreading knowledge, saving lives. J Med Oncl Ther. 2023;8(6):180

Visit for more related articles at Journal of Medical Oncology and Therapeutics

Abstract

   

Introduction

Ovarian Cancer Awareness Month, observed annually in September, serves as a crucial reminder of the significance of understanding, preventing, and detecting ovarian cancer. As the fifth most common cancer among women, ovarian cancer often goes undetected until it reaches advanced stages, making awareness campaigns pivotal in saving lives. This month-long initiative is not only about painting the world in teal, the designated color for ovarian cancer awareness, but also about spreading knowledge that empowers individuals to recognize early signs, reduce risk factors, and support on-going research for improved treatments [1].

Often referred to as the "silent killer," ovarian cancer is notorious for its subtle symptoms in the early stages. Women may experience bloating, abdominal pain, changes in bowel habits, and feelings of fullness, symptoms that are easily dismissed or attributed to other less serious conditions [2].

This lack of specific symptoms makes early detection challenging, contributing to the alarming statistics surrounding ovarian cancer. Awareness campaigns during Ovarian Cancer Awareness Month play a crucial role in breaking the silence and ensuring that women and healthcare professionals alike remain vigilant [3].

Knowledge is power when it comes to preventing ovarian cancer. While the exact cause of ovarian cancer remains unclear, certain risk factors have been identified. Women with a family history of ovarian or breast cancer, those who have inherited mutations in the BRCA1 or BRCA2 genes, and individuals with a personal history of breast, colorectal, or endometrial cancer face an elevated risk. Age, reproductive history, and hormone replacement therapy also play roles in influencing ovarian cancer risk. By understanding these risk factors, women can make informed decisions about their health and engage in proactive measures [4].

Ovarian cancer is most treatable when detected early, underscoring the critical importance of regular health check-ups and awareness of potential symptoms. During Ovarian Cancer Awareness Month, emphasis is placed on educating women about the significance of recognizing subtle changes in their bodies and seeking medical attention promptly. Routine pelvic exams, transvaginal ultrasounds, and CA-125 blood tests are among the diagnostic tools that can aid in early detection. Increased awareness encourages women to prioritize their health and engage in regular screenings, ultimately improving the chances of successful treatment [5].

Beyond the physical challenges posed by ovarian cancer, the disease has a profound impact on the emotional and psychological well-being of those affected. Ovarian Cancer Awareness Month provides an opportunity to shed light on the mental health aspects of the journey [6].

Support groups, counselling services, and educational resources contribute to a holistic approach to care. By acknowledging the emotional toll of ovarian cancer, the awareness month aims to foster a supportive community and help women navigate the complexities of their diagnosis [7].

Ovarian Cancer Awareness Month also serves as a platform to highlight recent breakthroughs in ovarian cancer research. Advances in understanding the molecular mechanisms of the disease, developments in targeted therapies, and progress in immunotherapy are among the promising areas of study. By showcasing these advancements, the awareness month encourages continued support for research initiatives that can lead to more effective treatments and, ultimately, a cure for ovarian cancer [8].

Ovarian Cancer Awareness Month is a crucial annual initiative that goes beyond the symbolic teal ribbons and social media hash tags. It is a call to action, a commitment to spreading knowledge that can save lives, and a collective effort to make strides in research and advocacy. As we don teal in September, let us stand united in the fight against ovarian cancer, fostering a world where early detection is the norm, survivors thrive, and, one day, a cure becomes a reality [9].

Amidst the awareness efforts and on-going research, it is essential to celebrate the resilience and strength of ovarian cancer survivors. Their stories serve as beacons of hope, inspiring others and demonstrating the progress made in the fight against this disease. Ovarian Cancer Awareness Month provides a platform to honour survivors, share their experiences, and emphasize the importance of continued support for those currently undergoing treatment [10].

conclusion

Ovarian Cancer Awareness Month is a crucial annual initiative that goes beyond the symbolic teal ribbons and social media hash tags. It is a call to action, a commitment to spreading knowledge that can save lives, and a collective effort to make strides in research and advocacy. As we don teal in September, let us stand united in the fight against ovarian cancer, fostering a world where early detection is the norm, survivors thrive, and, one day, a cure becomes a reality.

References

  1. Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18(7):407-18.

    2. Indexed at, Google Scholar, Cross Ref

  2. Pantel K, Alix-Panabières C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol. 2009;6(6):339-51.

    3. Indexed at, Google Scholar, Cross Ref

  3. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3(6):401-10.

    4. Indexed at, Google Scholar, Cross Ref

  4. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst. 1999;91(11):916-32.

    5. Indexed at, Google Scholar, Cross Ref

  5. O'Connell JB, Maggard MA, Liu JH,et al. Rates of colon and rectal cancers are increasing in young adults. Am Surg. 2003 ;69(10):866-72.

    6. Indexed at, Google Scholar, Cross Ref

  6. Xing L, Thorndyke B, Schreibmann E,et al. Overview of image-guided radiation therapy. Medical Dosimetry. 2006;31(2):91-112.

    7. Indexed at, Google Scholar, Cross Ref

  7. Hamilton W. Five misconceptions in cancer diagnosis. Br J Gen Pract. 2009;59(563):441-7.

    8. Indexed at, Google Scholar, Cross Ref

  8. Munir K, Elahi H, Ayub A, Frezza F, Rizzi A. Cancer diagnosis using deep learning: a bibliographic review. 2019;11(9):1235.

    9. Indexed at, Google Scholar, Cross Ref

  9. Tiller KE, Tessier PM. Advances in antibody design. Annu Rev Biomed. Eng. 2015;17:191-216.

    10. Indexed at, Google Scholar, Cross Ref

  10. Lampropoulos GK, Spengler PM. Helping and change without traditional therapy: Commonalities and opportunities. Couns Psychol Q. 2005;18(1):47-59.

    11. Indexed at, Google Scholar, Cross Ref

     

     

Get the App